Skip to content

The hysteroscopic morcellator versus the bipolar resectoscope for removal of residual placental tissue: a randomized controlled trial.

The hysteroscopic morcellator versus the bipolar resectoscope for removal of residual placental tissue: a randomized controlled trial. - Hysteroscopic morcellator versus bipolar resectoscope: placental tissue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38083
Enrollment
37
Registered
2011-01-18
Start date
2011-05-04
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

remainders of the afterbirth in the womb residual placental tissue

Interventions

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with residual placental tissue as seen by ambulant diagnostic hysteroscopy who are planned for hysteroscopic surgery.

Exclusion criteria

Exclusion criteria: Patients with: • Visual or pathological (e.g. on biopsy) evidence of malignancy preoperatively or at the time of operation. • Untreated cervical stenosis making safe access for operative hysteroscopy impossible as diagnosed preoperatively or at the time of operation. • A contra-indication for operative hysteroscopy.

Design outcomes

Primary

MeasureTime frame
Installation and operating time. Performing a second look hysteroscopy after 6 weeks checking for intrauterine adhesions, comparing the 2 techniques.

Secondary

MeasureTime frame
Comparing data on peri- and post operative complications (e.g. fluid deficit, conversion rates, perforation, burns, postoperative infection), availability of tissue for pathology analysis and pathology results, and efficiency at 6 weeks follow-up.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)